Cingulate Inc. Gains 146.12%
![Cingulate Inc. Gains 146.12%](https://stocktreats.com/storage/quote/default.jpg)
Cingulate Inc. (CING:NASDAQ) soared at $9.82, a gain of 146.1%. On Thu, Dec 28, 2023, CING:NASDAQ hit a New 2-Week High of $9.82. The stock got featured on our News Catalysts scanner on Wed, Dec 06, 2023 at 10:21 AM in the 'MISCELLANEOUS' category. From Fri, Dec 15, 2023, the stock recorded 50.00% Up Days and 33.33% Green Days
The stock spiked on Thu, Dec 28, 2023 at $12.7 with a volume of 26M+.
About Cingulate Inc. (CING:NASDAQ)
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...
Top 10 Gainers:
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 203.23%
- Sidus Space Inc. (SIDU:NASDAQ), 163.16%
- Cingulate Inc. (CING:NASDAQ), 146.12%
- Peak Bio Inc Com (PKBO:NASDAQ), 117.73%
- SenesTech, Inc. (SNES:NASDAQ), 100.58%
- Ucommune International Ltd (UK:NASDAQ), 71.38%
- Signature Bank (SBNY:NASDAQ), 68.18%
- DatChat Inc. (DATS:NASDAQ), 63.68%
- Microbot Medical Inc. (MBOT:NASDAQ), 55.3%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 44.38%